NewsRoom Articles

WednesdayDec 10, 2025 10:00 am

Optimal Treatment Timing Could Boost Cancer Therapy Efficacy

Administering chemotherapy at specific times could significantly improve outcomes for brain cancer patients. Washington University in St. Louis researchers discovered that treatment timing plays a crucial role in how effectively glioblastoma patients respond to standard drug protocols. Funding came from NCI, Siteman Cancer Center, and National Institutes of Health, with the cancer center operating at WashU Medicine and Barnes-Jewish Hospital. Examining glioblastoma's resistance to treatment despite affecting hundreds of thousands annually, the findings were published in the Journal of Neuro-Oncology. While Temozolomide remains the go-to chemotherapy compound for this malignancy, many patients see limited benefits. Cancer cells typically activate MGMT,…

MondayDec 08, 2025 10:00 am

Study Proposes Overhaul of US Lung Cancer Screening Guidelines

A new analysis is calling for major changes to how the United States screens for lung cancer. Current rules, the study argues, leave out most people who eventually develop the disease. Researchers behind the study say the system used today is far too narrow and fails to capture the full range of Americans who end up at risk. The work, published in JAMA Network Open, examined nearly one thousand lung cancer cases treated at Northwestern Medicine over a five year span. Researchers set out to determine how many of those patients would have qualified for routine CT scans under the…

WednesdayDec 03, 2025 10:00 am

EV Expertise Fuels Successes in Chinese-Made Flying Cars

China's battery-car mastery is propelling its flying vehicle manufacturers ahead of global rivals. Expertise developed through years of electric vehicle production and unmanned aircraft development is giving domestic companies a distinct edge in the nascent aerial mobility market. Aridge, a division of XPeng's automotive business, operates a production facility in Guangzhou capable of assembling one vehicle every thirty minutes at peak capacity. Trial manufacturing launched last month with consumer deliveries planned for next year following more than 7,000 advance orders. Its modular system uses a lightweight six-rotor aircraft that ascends vertically and nests inside a wheeled ground vehicle called the…

WednesdayNov 26, 2025 10:00 am

Nvidia’s Great Earnings Report Fails to Dim AI Investors’ Fears

Nvidia’s great earnings report failed to calm the growing unease around the AI trade, and that tension shaped the mood in markets this week. The company’s blockbuster quarter reaffirmed that demand for AI hardware remains powerful, yet instead of settling the debate, it exposed how sharply divided investors have become over the long term payoff of surging AI investments. Its shares surged at the open on Thursday last week and briefly pulled other AI and tech names with them but the lift evaporated within hours as traders reassessed what the results actually meant. Major indexes traced that same arc, climbing…

FridayNov 21, 2025 10:30 am

Building Global Audience Through Live Competition: How SEGG Media Corporation (NASDAQ: SEGG) Is Scaling Sports Content and Female Motorsport Visibility

Sports.com has surpassed 45 million cumulative live-stream views since launch, fueled by expanding motorsport coverage and global football partnerships Driver Jorden Dolischka became the first woman ever to reach the podium in Gulf Radical Cup history The company secured title sponsorship of Soccerex Miami 2025, placing Sports.com alongside elite clubs and global football leaders ahead of the 2026 FIFA World Cup In an entertainment market dominated by endlessly expanding archives, a different form of content is proving more durable and harder to replicate live competition. Unlike recorded programming, live sports draw audiences at the exact moment events unfold, creating concentrated…

WednesdayNov 19, 2025 10:00 am

Study identifies Biomarker to Predict Success of Immunotherapy, Chemo for Breast Cancer

Researchers from the University of Illinois Urbana-Champaign have discovered a protein that can predict which breast cancer patients will respond well to chemotherapy and immunotherapy. After conducting genome-wide screening in human cancer cells, the research team found that the FGD3 protein was a promising biomarker in determining chemotherapy and immunotherapy efficacy. Patients with high FGD3 levels responded favorably to treatment across all breast cancer types, while those with low levels show poor responses, Professor of biochemistry David J. Shapiro notes. The findings build on 2021 research when the team developed ErSO, an experimental drug that killed 100 percent of breast…

MondayNov 17, 2025 10:00 am

EV Sales in China Set New Record in October

Data from the China Association of Automobile Manufacturers (CAAM) has revealed that China sold 1.7 million electric and plug-in hybrid vehicles in October, setting a new monthly record for the rapidly expanding electric vehicle market. EV makers like BYD and Nio surpassed September sales by roughly 111,000 units, with year-over-year growth hitting 20 percent compared to October 2024. The figure includes exports, which totaled 256,000 vehicles, leaving about 1.5 million for the domestic market. Most of the growth was spurred by increased battery-electric vehicle (BEV) sales. Pure electric sales reached 1.1 million units, up 32% from last year, outpacing the…

FridayNov 14, 2025 9:45 am

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Targets Glioblastoma with Innovative Therapies, Addressing One of Oncology’s Greatest Unmet Needs

Glioblastoma multiforme (“GBM”) is an aggressive brain cancer with limited treatment options, and CEO John Climaco emphasized the company’s commitment to overcoming the blood-brain barrier, a key obstacle in brain cancer therapy. Lead candidate TPI 287, an abeotaxane, has shown early evidence of appearing to cross the blood-brain barrier and producing clinical responses. Phase 2 planning is underway following encouraging data from a Phase 1 combination study with bevacizumab (Avastin). The company’s repurposed global clinical network and regulatory progress position it for potential late-stage development in 2026. TPI 287 holds multiple Orphan Drug Designations, covering gliomas, neuroblastoma, and other CNS-related…

WednesdayNov 12, 2025 10:00 am

UK Government Announces $18.4M in Awards to Support Quantum Computing Projects

British officials have allocated $18.4 million in awards to support over a dozen quantum computing projects. The Quantum Sensing Mission Primer awards' goal is quite ambitious: deploy quantum computers that surpass current supercomputers by 2036. Science minister Patrick Vallance called the technology revolutionary, noting that it could transform medical diagnostics and slash computation times from decades to seconds. Cumulatively, the UK has pledged $880 million to advance quantum technology development in the country. Innovate UK will fund practical applications in medicine and infrastructure across 14 projects. One team is building a handheld eye scanner to replace the room-sized machines hospitals…

MondayNov 10, 2025 10:00 am

New Implants Defy Necessity of Brain Surgery Against Cancer

Microscopic wireless electronics that self-navigate to diseased brain tissue could eliminate the need for surgery when treating tumors and neurological conditions. Massachusetts Institute of Technology researchers demonstrated the technology in mice, showing how tiny devices injected into the bloodstream can autonomously locate target regions and deliver electrical stimulation without human guidance. These implants are fused with immune cells before injection, allowing them to slip past the body's defenses and cross the blood-brain barrier intact. Each device measures roughly one-billionth of a rice grain's length, built from layered organic semiconducting polymers positioned between metallic components to create an electronic structure. Scientists…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000